AAP
27
3
MAC
71
-4
DD
67
6
JCI
44
2
ZBH
48
-2
HSIC
53
2
AIV
62
-2
COP
47
2
APA
30
5
HES
68
2
HRB
85
-2
FLS
75
8
SRE
61
14
CFG
56
4
AZO
45
2
WM
80
-4
CRM
57
2
BIIB
45
-3
CINF
58
4
TGNA
66
2
AAP
27
3
MAC
71
-4
DD
67
6
JCI
44
2
ZBH
48
-2
HSIC
53
2
AIV
62
-2
COP
47
2
APA
30
5
HES
68
2
HRB
85
-2
FLS
75
8
SRE
61
14
CFG
56
4
AZO
45
2
WM
80
-4
CRM
57
2
BIIB
45
-3
CINF
58
4
TGNA
66
2
Financhill
Back

Chugai Pharmaceutical 10K Form

Sell
23

CHGCF
Chugai Pharmaceutical

Last Price:
29.75
Seasonality Move:
2.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCF News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCF

CHGCF Financial Statistics

Sales & Book Value

Annual Sales: $7.92B
Cash Flow: $595.48M
Price / Cash Flow: 21.99
Annual Sales: $6.59
Price / Book: 4.51

Profitability

EPS (TTM): 1.37480
Net Income (TTM): $2.26B
Gross Margin: $4.98B
Return on Equity: 20.99%
Return on Assets: 17.58%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 21 years for CHGCF is 62.81%.
  • The Selling, General & Administrative Expenses for CHGCF have been equal to 10.13% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCF is 29.29% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCF
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.53
Quick Ratio: 4.21

Price-to-Earnings

Trailing P/E Ratio: 21.1
Forward P/E Ratio: 0

CHGCF Technical Analysis vs Fundamental Analysis

Sell
23
Chugai Pharmaceutical (CHGCF) is a Sell

Is Chugai Pharmaceutical a Buy or a Sell?